Optimized Stent Performance

COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.5
The revolutionary COBRA PzF NCS is a new nanocoated, non drug-eluting stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.1
The revolutionary COBRA PzF NCS is a new nanocoated, non drug-eluting stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT requirement.1
In the FDA PzF SHIELD IDE trial, COBRA PzF NCS demonstrated an excellent safety profile with minimum 1-month DAPT.1,2
Several additional studies demonstrated low rates of stent thrombosis, zero late stent thrombosis with low DAPT.
Stent Thrombosis2
TLR‡2
Month DAPT1
minimum requirement
Polyzene-F is a nano-thin surface coating that has been studied extensively in the past 20+ years, demonstrating thrombo-resistant, anti-inflammatory and rapid healing effects in preclinical studies.3-7*
Polyzene-F is a nano-thin surface coating that has been studied extensively in the past 20+ years, demonstrating thrombo-resistant, anti-inflammatory and rapid healing effects in preclinical studies.3-7*
COBRA PzF NCS is approved and commercially available for purchase in the U.S. Contact a CeloNova Sales Representative today for more information.